CohBar, Inc. Announces Third Quarter 2016 Financial Results

Nov 14, 2016

CohBar, Inc.’s CEO Simon Allen to Present at BIO Investor Forum 2016

Oct 18, 2016

CohBar, Inc. Announces Discovery of New Peptides in the Mitochondrial Genome

Oct 13, 2016

CohBar Advances First-in-Class Mitochondria Based Therapeutic to IND-Enabling Activities

Sep 30, 2016

CohBar, Inc. Announces Second Quarter 2016 Financial Results

Aug 15, 2016

CohBar, Inc. to Hold 2016 Annual Shareholder Meeting and Investor Update June 14, 2016

May 31, 2016

CohBar, Inc. Announces First Quarter 2016 Financial Results

May 13, 2016

CohBar, Inc. Announces Preclinical Proof-of-principle Publication for SHLP Mitochondrial-derived Peptides and their Role in Metabolic Regulation and Cell Viability

Apr 11, 2016

CohBar, Inc. Announces Fourth Quarter 2015 Financial Results

Mar 9, 2016

CohBar, Inc. Appoints Simon Allen as Chief Executive Officer

Mar 8, 2016